NewsBenzinga디코이 테라퓨틱스, 생물방어 파이프라인의 전임상 및 임상 개발 지원을 위해 비희석형 연방 보조금 및 공중보건 협력 모색 중 디코이 테라퓨틱스, 생물방어 파이프라인의 전임상 및 임상 개발 지원을 위해 비희석형 연방 보조금 및 공중보건 협력 모색 중 Benzinga 2026.09.22 11:35 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 Ex-Carlyle Executive Launches Asia Secondaries Firm as $3 Trillion Sits Locked in Private Funds 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report